Two polymorphic sites in the sequence of the p53 gene, a BstUI restriction site at codon 72 in exon 4 and an MspI site in intron 6, have been proposed as responsible for the susceptibility to lung cancer [7, 8]. The gene discussed is TP53; the disease is lung carcinoma.